Skip to main content
. 2001 Oct 23;2001(4):CD003159. doi: 10.1002/14651858.CD003159

Nappi 1997.

Methods multicentre, double blind, randomized, placebo controlled, parallel groups
Participants SDAT or MID mild to moderate; 51patients received nicergoline, 50 placebo; age 60‐80 yr.
Interventions Nicergoline or Placebo 30mg. twice a day (os) for 12 months
Outcomes SCAG, MMSE, CGI for efficacy; adverse events for safety
Notes